II-17 upregulation in BAL-fluid during acute rejection after lung transplantation: a 3 months follow-up

B. M. Vanaudenaerde, L. J. Dupont, W. A. Wuyts, S. Seghers, D. E. Van Raemdonck, G. M. Verleden (Leuven, Belgium)

Source: Annual Congress 2004 - Lung transplantation: update on clinical and experimental issues
Session: Lung transplantation: update on clinical and experimental issues
Session type: Thematic Poster Session
Number: 1148
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. M. Vanaudenaerde, L. J. Dupont, W. A. Wuyts, S. Seghers, D. E. Van Raemdonck, G. M. Verleden (Leuven, Belgium). II-17 upregulation in BAL-fluid during acute rejection after lung transplantation: a 3 months follow-up. Eur Respir J 2004; 24: Suppl. 48, 1148

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
12 month follow-up of lung recipients with chronic allograft dysfunction treated with extracorporeal photopheresis (ECP)
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx)
Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment
Year: 2003


Association between tacrolimus levels in the first fifteen days post lung transplant and rejection during the first year
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Exercise capacity in patients with cystic fibrosis at 6 and 12 months after lung transplantation
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018

A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010



Time course of functional recovery after lung transplantation; a one year follow-up
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010


Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003



A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011



Hepatocyte growth factor (HGF) in lung allografts
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005


KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Characteristics of patients surviving 10 years after lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 349s
Year: 2002

Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001

Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD)
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017

Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001

Bronchial epithelial cell B7-1 and B7-2 mRNA expression after lung transplantation: a role in allograft rejection?
Source: Eur Respir J 2002; 20: 165-169
Year: 2002



Azithromycin treatment in patients with BOS after lung transplantation
Source: ISSN=ISSN 1810-6838, ISBN=, page=178
Year: 2005